Cannabis use correlates of syringe sharing among injection drug users

American Journal on Addictions

Volumn 19, Issue 3, 2010, Pages 231-237

  Jutras Aswad, Didier ^a,b,c   Zang, Geng ^a   Bruneau, Julie ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; DIAMORPHINE;

ABSTINENCE; ADULT; ALCOHOL CONSUMPTION; ARTICLE; BEHAVIOR; CANADA; CANNABIS ADDICTION; COHORT ANALYSIS; FEMALE; HEROIN DEPENDENCE; HOUSING; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; RISK; SELF REPORT; SYRINGE; SYRINGE SHARING; UNSTABLE HOUSING;

ADULT; FEMALE; HUMANS; MALE; MARIJUANA SMOKING; NEEDLE SHARING; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 77951096725     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2010.00031.x     Document Type: Article

References (38)

1. Fischer B, Manzoni P, Rehm J. Comparing injecting and non-injecting illicit opioid users in a multisite Canadian sample (OPICAN Cohort). Eur Addict Res. 2006 12 : 230 239. (Pubitemid 44387453)
2. Ben Diane MK, Feroni I, Poncet M, et al. Chief health risks associated with intravenous heroin and cocaine abuse. Press Med. 2000 29 : 453 457.
3. Santibanez SS, Garfein RS, Swartzendruber A, et al. Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. J Urban Health. 2006 83 : 86 100. (Pubitemid 44337045)
4. Abdala N, Stephens PC, Griffith BP, et al. Survival of HIV-1 in syringes. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 20 : 73 80. (Pubitemid 29045473)
5. Bruneau J, Daniel M, Kestens Y, et al. Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programmes. J Epidemiol Community Health. 2008 62 : 804 810.
6. Secteur Vigie et Protection. Appel à la vigilance: Recrudescence d'infections par le VIH et le VHC chez les utilisateurs de drogues injectables de Montréal. Montreal, Canada. Available from : http://www.santepub-mtl. qc.ca/Mi/vigilance/31082006.html (Accessed 2 October 2006): Direction de la Santé Publique, Agence de la santé et des services sociaux de Montréal 2006.
7. Miller CL, Kerr T, Frankish JC, et al. Binge drug use independently predicts HIV seroconversion among injection drug users: Implications for public health strategies. Subst Use Misuse. 2006 41 : 199 210. (Pubitemid 43068283)
8. Wood E, Tyndall MW, Spittal PM, et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help CMAJ. 2001 165 : 405 410. (Pubitemid 32885418)
9. Drake S, Swift W, Hall W, et al. Drug use, HIV risk-taking and psychosocial correlates of benzodiazepine use among methadone maintenance clients. Drug Alcohol Depend. 1993 34 : 67 70. (Pubitemid 24036392)
10. Hartgers C, van Ameijden EJ, Van Den Hoek JA, et al. Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting drug users. Public Health Rep. 1992 107 : 675 681.
11. PHAC. I-Track. Enhanced Surveillance of Risk Behaviours among People Who Inject Drugs. Public Health Agency of Canada 2006.
12. Budney AJ, Bickel WK, Amass L. Marijuana use and treatment outcome among opioid-dependent patients. Addiction. 1998 93 : 493 503. (Pubitemid 28188069)
13. Walley AY, Krupitsky EM, Cheng DM, et al. Implications of cannabis use and heavy alcohol use on HIV drug risk behaviors in Russian heroin users. AIDS Behav. 2008 12 : 662 669.
14. Weizman T, Gelkopf M, Melamed Y, et al. Cannabis abuse is not a risk factor for treatment outcome in methadone maintenance treatment: A 1-year prospective study in an Israeli clinic. Aust N Z J Psychiatry. 2004 38 : 42 46. (Pubitemid 38443677)
15. Patrick DM, Strathdee SA, Archibald CP, et al. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. Int J STD AIDS. 1997 8 : 437 445.
16. Ramaekers J, Kauert G, Theunissen E, et al. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. J Psychopharmacol. 2009 23 : 266 277.
17. Hart CL, van Gorp W, Haney M, et al. Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology. 2001 25 : 757 765. (Pubitemid 32995958)
18. Vadhan NP, Hart CL, van Gorp WG, et al. Acute effects of smoked marijuana on decision making, as assessed by a modified gambling task, in experienced marijuana users. J Clin Exp Neuropsychol. 2007 29 : 357 364.
19. Azorlosa JL, Greenwald MK, Stitzer ML. Marijuana smoking: Effects of varying puff volume and breathhold duration. J Pharmacol Exp Ther. 1995 272 : 560 569.
20. Hart CL, Ward AS, Haney M, et al. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans. Psychopharmacology (Berl). 2002 164 : 407 415. (Pubitemid 35435717)
21. D'Souza DC, Ranganathan M, Braley G, et al. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology. 2008 33 : 2505 2516.
22. Bechara A. Risky business: Emotion, decision-making, and addiction. J Gambl Stud. 2003 19 : 23 51.
23. Leigh BC. Alcohol and condom use: A meta-analysis of event-level studies. Sex Transm Dis. 2002 29 : 476 482.
24. Ross MW, Wodak A, Miller ME, et al. Sexual partner choice in injecting drug users from a "critical incident" measure: Its implications for estimating HIV spread. Sexol Rev. 1993 1 : 77 92.
25. Bruneau J, Lamothe F, Soto J, et al. Sex-specific determinants of HIV infection among injection drug users in Montreal. CMAJ. 2001 164 : 767 773. (Pubitemid 32511036)
26. Nixon LN. Cannabis use and treatment outcome in methadone maintenance. Addiction. 2003 98 : 1321 1322 author reply 1322 1323.
27. Stoltz JA, Wood E, Small W, et al. Changes in injecting practices associated with the use of a medically supervised safer injection facility. J Public Health (Oxf). 2007 29 : 35 39.
28. Zeger SL, Liang KY. An overview of methods for the analysis of longitudinal data. Stat Med. 1992 11 : 1825 1839. (Pubitemid 23015633)
29. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: A generalized estimating equation approach. Biometrics. 1988 44 : 1049 1060.
30. Corneil TA, Kuyper LM, Shoveller J, et al. Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users. Health Place. 2006 12 : 79 85. (Pubitemid 41501779)
31. Bambico FR, Katz N, Debonnel G, et al. Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J Neurosci. 2007 27 : 11700 11711. (Pubitemid 350006914)
32. Martin AB, Fernandez-Espejo E, Ferrer B, et al. Expression and function of CB1 receptor in the rat striatum: Localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. Neuropsychopharmacology. 2008 33 : 1667 1679. (Pubitemid 351684717)
33. Ferraro L, Tomasini MC, Cassano T, et al. Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate gamma-aminobutyric acid levels. J Neurosci Res. 2001 66 : 298 302. (Pubitemid 32912299)
34. Ferraro L, Tomasini MC, Gessa GL, et al. The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: An in vivo and in vitro study. Cereb Cortex. 2001 11 : 728 733. (Pubitemid 32718077)
35. Romero J, Berrendero F, Manzanares J, et al. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol. Synapse. 1998 30 : 298 308. (Pubitemid 28447177)
36. Saxon AJ, Calsyn DA, Greenberg DM, et al. Urine screening for marijuana among methadone-maintained patients. Am J Addict. 1993 2 : 207 211.
37. Valdez A, Cepeda A, Neaigus A, et al. Heroin transition risk among daily and non-daily cannabis users who are non-injectors of heroin. Int J Drug Policy. 2008 19 : 442 449.
38. Darke S. Self-report among injecting drug users: A review. Drug Alcohol Depend. 1998 51 : 253 263 discussion 267 268.